|
Granulocyte Colony-Stimulating Factor Clinical Trials
8 actively recruiting trials across 6 locations
Also known as: CSF3, Colony Stimulating Factor 3, Colony-Stimulating Factor (Granulocyte), Colony-Stimulating Factor 3, Filgrastim +7 more
Pipeline
Phase 1: 3Phase 2: 3Phase 3: 1Phase 1/2: 1
Top Sponsors
- Washington University School of Medicine1
- Shanxi Bethune Hospital1
- Masonic Cancer Center, University of Minnesota1
- Kura Oncology, Inc.1
- Hackensack Meridian Health1
Indications
- Cancer8
- Acute Myeloid Leukemia4
- Aml2
- Myeloproliferative Neoplasm2
- Myelodysplastic Syndrome2
Other2 trials
Gilbert, Arizona1 trial
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Banner MD Anderson Cancer Center
Phase 1
Duarte, California1 trial
Minneapolis, Minnesota1 trial
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
Masonic Cancer Center, University of Minnesota
Phase 2
St Louis, Missouri1 trial
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
Washington University School of Medicine
Phase 1/2
Hackensack, New Jersey1 trial
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
Hackensack Meridian Health - John Theurer Cancer Center
Phase 1
Seattle, Washington1 trial
Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Fred Hutch/University of Washington Cancer Consortium
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.